Naga Vara Kishore Pillarsetty, PhD

Naga Vara Kishore Pillarsetty, PhD

Areas of Expertise

My Specialties

  • Clinical trials
  • Radiotracers
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a radiochemist working in Memorial Hospital’s Department of Radiology with a focus on the synthesis and development of positron-emission tomography (PET) imaging probes. I have a PhD degree in chemistry and while a post-doctoral fellow at Memorial Sloan Kettering, I developed an interest in biology. During my fellowship, I synthesized fluorine-18 and iodine-124 labeled molecules, which can act as PET probes for imaging HSV1-tk gene expression or function as a marker for proliferation, a hallmark of cancer. The information obtained from PET imaging was used to assess the biological status of the tumor cells.

Read more

Since many disease states, including cancer, involve alterations in basic biological functions of the cells, information regarding these alterations can aid in diagnosis of disease and help in planning the most effective treatment. Non-invasive PET imaging is powerful technique which provides us with vital biological information which can be extremely useful in disease diagnosis and management. With this background, I became interested in development of PET/radiochemical probes which augment solving fundamental biological problems. Since this requires a multidisciplinary effort, I am extremely lucky and grateful to have colleagues who are experts in fields ranging from chemistry to radiology. We enjoy extremely fruitful collaborations and interact very closely on all aspects of research. My current research interests and collaborations include:

  • synthesis and development of fluorine-18 and iodine-124 labeled generic PET tracers for studying functional differences between tumor cells and normal cells,
  • development of radiolabeling protocols for tyrosine kinase targeted PET imaging agents,
  • using animal models to evaluate efficacy of the PET tracers, and
  • developing new radiolabeling protocols and methodologies.
What I Do at MSK

I'm a radiochemist, which is a doctor and scientist who studies radioactive elements.

  • Director, Preclinical Radiochemistry & Training, Lab Head
Areas of Expertise

My Specialties

  • Clinical trials
  • Radiotracers
Education & Honors

Education

  • PhD, University of Missouri. Columbia

Fellowships

  • Memorial Sloan Kettering Cancer Center

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients
Request an appointment by logging in to MSK MyChart or calling your Care Team. If you are not enrolled in MSK MyChart, ask your Care Team to send you an invitation. You can also go to MSK MyChart and select “Sign up now.”

Contact and Location

Dr. Pillarsetty sees patients at one location.

Office Phone
Location
New York, NY
1275 York Avenue New York NY 10065

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Radiochemistry and Imaging Sciences Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Pillarsetty’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Naga Vara Kishore Pillarsetty discloses the following relationships and financial interests:

  • AbbVie
    Equity
  • Adjuvance Technologies
    Intellectual Property Rights
  • Amedisys
    Equity
  • Bayer
    Equity
  • Celldex Therapeutics
    Equity
  • Evergreen Theragnostics
    Equity; Professional Services and Activities
  • General Electric
    Equity
  • Ionis Pharmaceuticals, Inc.
    Equity
  • Johnson & Johnson
    Equity
  • Jubilant DraxImage Inc.
    Professional Services and Activities
  • Lantheus Medical Imaging, Inc.
    Equity
  • Revolution Medicines
    Equity
  • Samus Therapeutics LLC
    Intellectual Property Rights
  • Verastem
    Equity
  • Viking Therapeutics Inc
    Equity
  • Y-mAbs Therapeutics, Inc.
    Intellectual Property Rights

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures